Clinical Trial Data Evaluating a Treatment for Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE) in Patients With Active Cancer

Host: Jennifer Caudle, DO <br> Guest: Steven Fein, MD <br> <p><span>Here to delve into venous thromboembolism (VTE) clinical trial data on XARELTO^®, a treatment option approved for deep vein thrombosis (DVT) and pulmonary embolism (PE), is Dr Steven Fein. He will highlight the EINSTEIN clinical trials, a subgroup analysis, and the results of a randomized, open-label pilot trial for the treatment of DVT and/or PE in patients with active cancer.</span></p> <p><span>This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultant is a paid speaker for Janssen Pharmaceuticals, Inc. The speaker is presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen.</span></p>